9 Years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): Comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC)

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 10, 2009, Pages 971-978

  Guran, Tulay ^a   Turan, Serap ^a   Bircan, Rifat ^b   Bereket, Abdullah ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

D thyroxine; Pituitary resistance to thyroid hormones; TRIAC; Triiodothyroacetic acid

Indexed keywords

ALKALINE PHOSPHATASE; DEXTROTHYROXINE; PROPYLTHIOURACIL; THYROID HORMONE; THYROTROPIN; TIRATRICOL;

ARTICLE; BIOCHEMISTRY; CASE REPORT; CHILD; CODON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; EXON; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GOITER; HEART PALPITATION; HEAT INTOLERANCE; HUMAN; HYPERTHYROIDISM; MISSENSE MUTATION; MOLECULAR BIOLOGY; NERVOUSNESS; PITUITARY RESISTANCE TO THYROID HORMONE; SCHOOL CHILD; SLEEP DISORDER; SYMPTOMATOLOGY; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; TRBETA GENE; TREATMENT DURATION;

ALKALINE PHOSPHATASE; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; PRENATAL DIAGNOSIS; SEX HORMONE-BINDING GLOBULIN; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 71049177020     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. th Ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 2005; 1109-1129.
2. Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem 2006; 43: 431-440.
3. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006; 95: 1635-1641. (Pubitemid 44863818)
4. John SW, Weitner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leucocytes. Nucleic Acid Res 1991; 19: 408.
5. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee VK. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest 1994; 94: 506-515. (Pubitemid 24978970)
6. Hamon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J. Hyperthyroidism due to a selective pituitary resistance to thyroid hormone in a 15-month-old boy: efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 1988; 5: 1089-1093. (Pubitemid 18277236)
7. Dorey F, Strauch G, Gayno JP. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D-thyroxine: a study in three patients. Clin Endocrinol (Oxf) 1990; 32: 221-228.
8. Krawczynska H, Wojcik-Musialek K, Illig R. 10 years of successful treatment with dextrothyroxine in a girl with TSH-induced hyperthyroidism. Horm Res 1991; 35: 213-216.
9. Hamon B, Hamon P, Bovier-Lapierre M, Pugeat M, Savagner F, Rodien P, Orgiazzi J. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up. Thyroid 2008; 18: 35-44. (Pubitemid 351170442)
10. Takeda T, Suzuki S, Liu RT, DeGroot LJ. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 1995; 80: 2033-2040.
11. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983; 6: 217-223.
12. Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 1997; 7: 775-778. (Pubitemid 28086211)
13. Dulgeroff AJ, Geffher ME, Koyal SN, Wong M, Hershman JM. Bromocriptine and TRIAC therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1992; 75: 1071-1075.
14. Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. J Endocrinol Invest 2005; 28: 657-662. (Pubitemid 43162877)
15. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P. Evidence for secretion of thyroropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 1994; 78: 1034-1039. (Pubitemid 24143019)
16. Sadow P, Reutrakul S, Weiss RE, Refetoff S. Resistance to thyroid hormone in the absence of the mutations in the thyroid hormone receptor genes. Curr Opin Endocrinol Diabetes 2000; 7: 253-259. (Pubitemid 30727449)
17. Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, Forloni F, Pinchera A, Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990; 71: 19-25. (Pubitemid 20228298)
18. Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D. Prenatal diagnosis of thyroid hormone receptors. J Clin Endocrinol Metab 1999; 84: 405-410. (Pubitemid 29075660)
19. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 2007; 21: 277-305. (Pubitemid 46888195)
20. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004; 292: 691-695. (Pubitemid 39062522)